XII Medical
Developer of an implantable neurostimulation device designed to alleviate sleep apnea. The company develops a minimally invasive outpatient technology that does not allow the muscles in the throat to ...
Valuation
$117M
Latest known
Share Price
N/A
Total Raised
$82.6M
Last Round
N/A